Stefanie Zschäbitz Selected Research

Fatigue

12/2023	First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
1/2023	Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefanie Zschäbitz Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 01/2011
15	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 01/2018
14	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2017
4	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2013
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020 - 01/2017
2	Neutropenia 12/2023 - 01/2023
2	Fatigue 12/2023 - 01/2023
2	Anemia 12/2023 - 08/2011
2	Disease Progression 10/2023 - 01/2022
2	Carcinoma (Carcinomatosis) 07/2023 - 01/2023
2	Cytokine Release Syndrome 09/2022 - 01/2022
2	COVID-19 09/2022 - 01/2022
2	Adenocarcinoma 03/2011 - 01/2011
1	Kidney Neoplasms (Kidney Cancer) 12/2023
1	Cognitive Dysfunction 11/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023
1	Testicular Neoplasms (Testicular Cancer) 02/2020
1	Acinar Cell Carcinoma 01/2020
1	Urologic Neoplasms (Urological Cancer) 12/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Carcinogenesis 02/2013
1	Postoperative Hemorrhage 08/2011
1	Chronic Renal Insufficiency 08/2011
1	Hemorrhage 08/2011
1	Critical Illness (Critically Ill) 08/2011
1	Pancreatic Fistula (Pancreatic Fistulas) 08/2011
1	Heart Failure 03/2011
1	Diabetes Mellitus 03/2011

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 12/2023 - 12/2019
4	enfortumab vedotinIBA 04/2024 - 01/2023
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2011
4	enzalutamideIBA 01/2024 - 01/2017
3	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 01/2023
3	talazoparibIBA 01/2024 - 01/2023
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 12/2023 - 09/2022
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2023
3	PlatinumIBA 07/2023 - 01/2017
3	Formaldehyde (Formol)FDA Link 01/2022 - 01/2020
3	ParaffinIBA 01/2022 - 01/2020
2	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 01/2023
2	CalciumIBA 12/2023 - 01/2022
2	NivolumabIBA 12/2023 - 01/2022
2	AndrogensIBA 11/2023 - 09/2023
2	claudin 6IBA 04/2023 - 03/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 01/2021
2	CytokinesIBA 01/2022 - 01/2022
2	cabazitaxel FDA Link 02/2020 - 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023
1	NectinsIBA 12/2023
1	Granzymes (Granzyme)IBA 10/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	ClaudinsIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	pembrolizumabIBA 01/2022
1	rucaparibIBA 01/2022
1	growth arrest-specific protein 6IBA 01/2022
1	Maraviroc FDA Link 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	AntigensIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	InterferonsIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Fetal Proteins (Fetoprotein)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2019
1	LipidsIBA 12/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019
1	lenvatinibIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	AntibodiesIBA 01/2017
1	Radium-223IBA 01/2017
1	taxaneIBA 01/2017
1	Abiraterone AcetateIBA 01/2017
1	VitaminsIBA 02/2013
1	Vitamin B Complex (B Vitamins)IBA 02/2013
1	Riboflavin (Vitamin B2)FDA LinkGeneric 02/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2013
1	CarbonIBA 02/2013
1	Hemoglobins (Hemoglobin)IBA 08/2011

Therapy/Procedure

9	Immunotherapy 04/2024 - 10/2019
9	Therapeutics 03/2024 - 06/2018
8	Castration 01/2024 - 01/2017
7	Drug Therapy (Chemotherapy) 07/2023 - 01/2017
2	Nephrectomy 03/2024 - 01/2022
2	Combined Modality Therapy 12/2023 - 01/2022
2	Critical Care (Surgical Intensive Care) 08/2011 - 03/2011
2	Pancreaticoduodenectomy 08/2011 - 03/2011
1	Drug Tapering 01/2023
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Stem Cell Transplantation 01/2017